TGTX logo

TG Therapeutics (TGTX) Total liabilities

annual total liabilities:

$355.33M+$186.24M(+110.15%)
December 31, 2024

Summary

  • As of today (June 23, 2025), TGTX annual total liabilities is $355.33 million, with the most recent change of +$186.24 million (+110.15%) on December 31, 2024.
  • During the last 3 years, TGTX annual total liabilities has risen by +$212.85 million (+149.39%).
  • TGTX annual total liabilities is now at all-time high.

Performance

TGTX Total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXbalance sheet metrics

quarterly total liabilities:

$419.40M+$64.07M(+18.03%)
March 1, 2025

Summary

  • As of today (June 23, 2025), TGTX quarterly total liabilities is $419.40 million, with the most recent change of +$64.07 million (+18.03%) on March 1, 2025.
  • Over the past year, TGTX quarterly total liabilities has increased by +$206.19 million (+96.70%).
  • TGTX quarterly total liabilities is now at all-time high.

Performance

TGTX quarterly total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXbalance sheet metrics

Total liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

TGTX Total liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+110.2%+96.7%
3 y3 years+149.4%+216.2%
5 y5 years+185.6%+306.4%

TGTX Total liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+163.2%at high+257.2%
5 y5-yearat high+234.3%at high+327.2%
alltimeall timeat high>+9999.0%at high>+9999.0%

TGTX Total liabilities History

DateAnnualQuarterly
Mar 2025
-
$419.40M(+18.0%)
Dec 2024
$355.33M(+110.1%)
$355.33M(-9.8%)
Sep 2024
-
$393.86M(+76.1%)
Jun 2024
-
$223.64M(+4.9%)
Mar 2024
-
$213.21M(+26.1%)
Dec 2023
$169.09M(+25.3%)
$169.09M(+1.7%)
Sep 2023
-
$166.30M(-7.8%)
Jun 2023
-
$180.40M(+6.2%)
Mar 2023
-
$169.93M(+25.9%)
Dec 2022
$134.99M(-5.3%)
$134.99M(+15.0%)
Sep 2022
-
$117.41M(-4.3%)
Jun 2022
-
$122.63M(-7.5%)
Mar 2022
-
$132.64M(-6.9%)
Dec 2021
$142.48M(+34.0%)
$142.48M(+45.1%)
Sep 2021
-
$98.17M(-0.1%)
Jun 2021
-
$98.27M(-5.0%)
Mar 2021
-
$103.41M(-2.7%)
Dec 2020
$106.29M(-14.6%)
$106.29M(+3.0%)
Sep 2020
-
$103.20M(+2.8%)
Jun 2020
-
$100.39M(-2.7%)
Mar 2020
-
$103.20M(-17.0%)
Dec 2019
$124.40M(+108.8%)
$124.40M(+4.4%)
Sep 2019
-
$119.12M(+27.6%)
Jun 2019
-
$93.38M(-5.0%)
Mar 2019
-
$98.28M(+65.0%)
Dec 2018
$59.58M(+96.1%)
$59.58M(+39.8%)
Sep 2018
-
$42.63M(+8.4%)
Jun 2018
-
$39.34M(+10.0%)
Mar 2018
-
$35.76M(+17.7%)
Dec 2017
$30.39M(+60.7%)
$30.39M(+36.7%)
Sep 2017
-
$22.24M(-4.3%)
Jun 2017
-
$23.22M(+4.5%)
Mar 2017
-
$22.21M(+17.5%)
Dec 2016
$18.91M(+58.9%)
$18.91M(-0.1%)
Sep 2016
-
$18.93M(+17.6%)
Jun 2016
-
$16.10M(+51.6%)
Mar 2016
-
$10.62M(-10.8%)
Dec 2015
$11.90M(+79.1%)
$11.90M(+7.3%)
Sep 2015
-
$11.10M(+4.1%)
Jun 2015
-
$10.66M(-3.5%)
Mar 2015
-
$11.04M(+66.1%)
Dec 2014
$6.64M(-17.5%)
$6.64M(-36.5%)
Sep 2014
-
$10.46M(+148.8%)
Jun 2014
-
$4.21M(+12.4%)
Mar 2014
-
$3.74M(-53.6%)
Dec 2013
$8.06M(+23.5%)
$8.06M(-16.6%)
Sep 2013
-
$9.66M(+27.4%)
Jun 2013
-
$7.58M(+13.4%)
Mar 2013
-
$6.69M(+2.5%)
Dec 2012
$6.52M(+33.1%)
$6.52M(-11.1%)
Sep 2012
-
$7.34M(+8.8%)
Jun 2012
-
$6.74M(+14.6%)
Mar 2012
-
$5.89M(+20.1%)
Dec 2011
$4.90M(-79.6%)
$4.90M(-73.3%)
Sep 2011
-
$18.36M(-10.5%)
Jun 2011
-
$20.51M(+2.8%)
Mar 2011
-
$19.96M(-16.8%)
Dec 2010
$24.00M
$24.00M(-3.1%)
DateAnnualQuarterly
Sep 2010
-
$24.77M(-2.4%)
Jun 2010
-
$25.38M(-8.1%)
Mar 2010
-
$27.60M(+286.0%)
Dec 2009
$7.15M(+27.1%)
$7.15M(-2.4%)
Sep 2009
-
$7.33M(-1.6%)
Jun 2009
-
$7.45M(+13.4%)
Mar 2009
-
$6.56M(+16.7%)
Dec 2008
$5.62M(+200.5%)
$5.62M(+13.3%)
Sep 2008
-
$4.96M(+12.3%)
Jun 2008
-
$4.42M(+147.4%)
Mar 2008
-
$1.79M(-4.6%)
Dec 2007
$1.87M(-3.7%)
$1.87M(+4.5%)
Sep 2007
-
$1.79M(-29.2%)
Jun 2007
-
$2.53M(+15.4%)
Mar 2007
-
$2.19M(+12.8%)
Dec 2006
$1.94M(+16.7%)
$1.94M(+37.4%)
Sep 2006
-
$1.41M(-36.1%)
Jun 2006
-
$2.21M(-1.4%)
Mar 2006
-
$2.25M(+34.9%)
Dec 2005
$1.67M(+39.3%)
$1.67M(-7.9%)
Sep 2005
-
$1.81M(+1.9%)
Jun 2005
-
$1.78M(+39.7%)
Mar 2005
-
$1.27M(+6.3%)
Dec 2004
$1.20M(+23.8%)
$1.20M(-18.9%)
Sep 2004
-
$1.47M(+136.2%)
Jun 2004
-
$624.40K(-17.6%)
Mar 2004
-
$757.80K(-21.6%)
Dec 2003
$966.00K(-10.8%)
$966.00K(-23.7%)
Sep 2003
-
$1.27M(+20.0%)
Jun 2003
-
$1.05M(-0.8%)
Mar 2003
-
$1.06M(-1.8%)
Dec 2002
$1.08M(+113.0%)
$1.08M(+115.0%)
Sep 2002
-
$503.90K(+17.8%)
Jun 2002
-
$427.70K(-11.8%)
Mar 2002
-
$484.70K(-4.7%)
Dec 2001
$508.60K(-75.6%)
$508.60K(-32.0%)
Sep 2001
-
$748.40K(+5.9%)
Jun 2001
-
$706.90K(-9.3%)
Mar 2001
-
$779.20K(-62.5%)
Dec 2000
$2.08M(+246.7%)
$2.08M(+95.9%)
Sep 2000
-
$1.06M(+95.7%)
Jun 2000
-
$542.50K(+9.4%)
Mar 2000
-
$495.90K(-17.3%)
Dec 1999
$600.00K(0.0%)
$600.00K(+200.0%)
Sep 1999
-
$200.00K(-50.0%)
Jun 1999
-
$400.00K(+33.3%)
Mar 1999
-
$300.00K(-50.0%)
Dec 1998
$600.00K(+50.0%)
$600.00K(0.0%)
Sep 1998
-
$600.00K(0.0%)
Jun 1998
-
$600.00K(+200.0%)
Mar 1998
-
$200.00K(-50.0%)
Dec 1997
$400.00K(+33.3%)
$400.00K(+33.3%)
Sep 1997
-
$300.00K(0.0%)
Jun 1997
-
$300.00K(0.0%)
Mar 1997
-
$300.00K(0.0%)
Dec 1996
$300.00K
$300.00K(-25.0%)
Sep 1996
-
$400.00K(0.0%)
Jun 1996
-
$400.00K

FAQ

  • What is TG Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for TG Therapeutics?
  • What is TG Therapeutics annual total liabilities year-on-year change?
  • What is TG Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for TG Therapeutics?
  • What is TG Therapeutics quarterly total liabilities year-on-year change?

What is TG Therapeutics annual total liabilities?

The current annual total liabilities of TGTX is $355.33M

What is the all time high annual total liabilities for TG Therapeutics?

TG Therapeutics all-time high annual total liabilities is $355.33M

What is TG Therapeutics annual total liabilities year-on-year change?

Over the past year, TGTX annual total liabilities has changed by +$186.24M (+110.15%)

What is TG Therapeutics quarterly total liabilities?

The current quarterly total liabilities of TGTX is $419.40M

What is the all time high quarterly total liabilities for TG Therapeutics?

TG Therapeutics all-time high quarterly total liabilities is $419.40M

What is TG Therapeutics quarterly total liabilities year-on-year change?

Over the past year, TGTX quarterly total liabilities has changed by +$206.19M (+96.70%)
On this page